Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
0.671 %
$ 44.4 M
Market Cap
-6.52
P/E
DYAI - COST OF REVENUE
Cost of Revenue DYAI - Dyadic International, Inc.
1.98 M
LAST VALUE
0.80%
2 YEAR CAGR
13.98%
5 YEAR CAGR
-14.73%
10 YEAR CAGR